Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: The CLASP IID 2-Year RCT and Registry Outcomes
Author(s): Firas Zahr Added: 1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more

Intervention
Managing LVOT Obstruction in Transcatheter Mitral Replacement with Dr Eleid
Author(s): Mackram F Eleid Added: 2 months ago
Explore advanced strategies for preventing and managing LVOT obstruction in transcatheter mitral valve replacement with Dr Mackram EleidThis presentation, part of Women As One's comprehensive Structural Interventions track, examines of a 90-year-old patient with severe mitral annular calcification, heart failure with preserved ejection fraction, and significant basal septal hypertrophy. Dr Eleid… View more

Intervention
Left Atrium Role in Secondary Mitral Regurgitation
Author(s): Markos Koukos , Yannis Dimitroglou , Dimitrios Tsartsalis , et al Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 8 months ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention
Atrioventricular (AV) Valves Summit 2023
Author(s): , Added: 2 years ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more

Imaging & Diagnostics

Intervention
Innovation and Development in Polymer Heart Valves: A New Era of Transcatheter Aortic Valve Replacement
Author(s): Yu Mao , Fengkai Liu , Xi Chen , et al Added: 2 months ago

Intervention
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
Author(s): Didier Tchétché Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more

Demographic

Intervention
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention